Compared side by side
MOTS-c vs humanin: how they differ
The short answer
Both are mitochondria-derived peptides: MOTS-c, in mice, activates AMPK, the pathway exercise triggers, improving insulin sensitivity and exercise capacity, and humanin, in cell and rodent studies, protects cells from programmed death and lowers the toxicity of amyloid-beta. Children of centenarians have higher humanin levels, but neither has been tested as a treatment in people. MOTS-c is taken 2–3 times a week, humanin weekly.
Side by side
| Compared | MOTS-c | Humanin |
|---|---|---|
| Category | Longevity | Longevity |
| Also known as | Mitochondrial Open Reading Frame of the 12S rRNA-c | HN, Mitochondrial-derived peptide |
| What it is | A peptide encoded by your mitochondrial DNA, the energy-producing organelles inside every cell. | Another mitochondrial-derived peptide. |
| How it works | Mitochondria-derived peptide that regulates metabolic homeostasis. In mouse and cell studies it activates the AMPK pathway, improves insulin sensitivity and exercise capacity, and slows some signs of aging. | Mitochondria-derived peptide with cytoprotective and neuroprotective effects. In cell and rodent studies (many using the more potent analog HNG) it reduces apoptosis, improves insulin sensitivity and lowers amyloid-beta toxicity. Higher levels were found in children of centenarians, though how it relates to longevity is unclear. |
| Commonly reported | More energy and better workout endurance over the first weeks, sometimes after a week or two of feeling tired. No human trial has tested it yet. | Subtle or no felt effect, and community reports are sparse. Children of centenarians have higher humanin levels, but it has never been tested as a treatment in people. |
| Studied range | Research range: 5–10 mg. Studied in research — not a recommendation. | Research range: 2–4 mg. Studied in research — not a recommendation. |
| How often | 2–3× weekly | Weekly |
| Half-life | Hours (short) | Unknown in humans |
| Route | SubQ injection, IM injection | SubQ injection |
| Typical run | 4–8 week cycles common, 2–3× per year. Common splits: Mon/Thu (2× weekly) or Mon/Wed/Fri (3× weekly). Limited long-term human data — none on continuous dosing. | Weekly dosing typical. Limited human data — most run 8–12 week cycles cautiously. |
| Evidence | Emerging: primarily preclinical / limited human data | Emerging: primarily preclinical / limited human data |
| Common side effects | Injection site reaction, mild fatigue first week | Injection site pain, mild fatigue |
- Category
- MOTS-cLongevity
- HumaninLongevity
- Also known as
- MOTS-cMitochondrial Open Reading Frame of the 12S rRNA-c
- HumaninHN, Mitochondrial-derived peptide
- What it is
- MOTS-cA peptide encoded by your mitochondrial DNA, the energy-producing organelles inside every cell.
- HumaninAnother mitochondrial-derived peptide.
- How it works
- MOTS-cMitochondria-derived peptide that regulates metabolic homeostasis. In mouse and cell studies it activates the AMPK pathway, improves insulin sensitivity and exercise capacity, and slows some signs of aging.
- HumaninMitochondria-derived peptide with cytoprotective and neuroprotective effects. In cell and rodent studies (many using the more potent analog HNG) it reduces apoptosis, improves insulin sensitivity and lowers amyloid-beta toxicity. Higher levels were found in children of centenarians, though how it relates to longevity is unclear.
- Commonly reported
- MOTS-cMore energy and better workout endurance over the first weeks, sometimes after a week or two of feeling tired. No human trial has tested it yet.
- HumaninSubtle or no felt effect, and community reports are sparse. Children of centenarians have higher humanin levels, but it has never been tested as a treatment in people.
- Studied range
- MOTS-cResearch range: 5–10 mg. Studied in research — not a recommendation.
- HumaninResearch range: 2–4 mg. Studied in research — not a recommendation.
- How often
- MOTS-c2–3× weekly
- HumaninWeekly
- Half-life
- MOTS-cHours (short)
- HumaninUnknown in humans
- Route
- MOTS-cSubQ injection, IM injection
- HumaninSubQ injection
- Typical run
- MOTS-c4–8 week cycles common, 2–3× per year. Common splits: Mon/Thu (2× weekly) or Mon/Wed/Fri (3× weekly). Limited long-term human data — none on continuous dosing.
- HumaninWeekly dosing typical. Limited human data — most run 8–12 week cycles cautiously.
- Evidence
- MOTS-cEmerging: primarily preclinical / limited human data
- HumaninEmerging: primarily preclinical / limited human data
- Common side effects
- MOTS-cInjection site reaction, mild fatigue first week
- HumaninInjection site pain, mild fatigue
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
MOTS-c
- Day 1–14 The first two weeks
- Day 14–28 Workouts often feel easier
- Day 28–56 Weeks 4 to 8: check your markers
- Day 56–84 Diminishing returns + cycle point
Humanin
- Day 1–28 Quiet month — nothing loud happens
- Day 28–56 Metabolic markers may be shifting
- Day 56–84 Good point to reassess
Together or one or the other
MOTS-c and humanin are a common stack: each lists the other among its common stacks.
Community · Humanin
The mitochondrial-peptide trio
MOTS-c, humanin and SS-31 work on three different angles of mitochondrial health — metabolic signaling, cell-death regulation and membrane integrity. No study has combined them; it's a popular longevity stack on that logic.
Questions people ask
How long do MOTS-c and humanin last?
The half-life of MOTS-c is hours (short). The half-life of humanin is unknown in humans.
How often are MOTS-c and humanin taken?
MOTS-c: 2–3× weekly. Routes: SubQ injection, IM injection. Humanin: weekly. Route: SubQ injection.
How are MOTS-c and humanin dosed in research?
The research range for MOTS-c is 5–10 mg. The research range for humanin is 2–4 mg. Studied in research — not a recommendation.
What are the common side effects of MOTS-c and humanin?
For MOTS-c, the library lists: injection site reaction, mild fatigue first week. For humanin: injection site pain, mild fatigue.
Are MOTS-c and humanin taken together?
MOTS-c and humanin are a common stack: each lists the other among its common stacks. MOTS-c, humanin and SS-31 work on three different angles of mitochondrial health — metabolic signaling, cell-death regulation and membrane integrity. No study has combined them; it's a popular longevity stack on that logic.